The activity of thymidine phosphorylase obtained from human uterine leiomyomas and studied in the presence of pyrimidine derivatives

Zeitschrift fur Naturforschung Section C - Journal of Biosciences

Volumn 52, Issue 9-10, 1997, Pages 670-675

  Miszczak Zaborska, Elzbieta ^a   Woźniak, Krystyna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Leiomyoma; Pyrimidine Derivatives; Thymidine Phosphorylase; Uterus

Indexed keywords

EID: 0031239220     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-1997-9-1015     Document Type: Article

References (36)

1. Baker B. R. and Kelley J. L. (1970), Irreversible enzyme inhibitors. CLXX. Inhbition of FUdR phosphorylase from Walker 256 tumor by 1-substituted uracils. J.Med.Chem. 13, 458-461.
2. Bradford M. A. (1976), A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein - dye binding. Anal. Biochem. 72, 248-254.
3. Desgranges C., Razaka G., Rabaud M. and Bricaud H. (1981), Catabolism of thymidine in human blood platelets. Purification and properties of thymidine phosphorylase. Biochim.Biophys.Acta. 654, 211-218.
4. Desgranges C., Razaka G., Rabaud M., Picard P., Dupuch F. and Bricaud H. (1982), The human blood platelet: A cellular model to study the degradation of thymidine and its inhibition. Biochem.Pharmacol. 31, 2755-2759.
5. Drabikowska A. K., Lissowska L., Dramiński M., Zgit-Wróblewska A and Shugar D. (1987), Acyclonucleoside analogues consisting of 5-and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E.coli uridine phosphorylase. Z. Naturforsch. 42c, 288-296.
6. Grancharov K., Mladenova J. and Golovinsky E. (1991), Inhibition of uridine phosphorylase by some pyrimidine derivatives. Biochem. Pharmacol. 41, 1769-1772.
7. Iigo M., Nishikata K.-I., Nakajima Y., Szinai I., Veres Z., Szabolcs A. and De Clercq E. (1990), Differential effects of 2,2′-anhydro-5-ethyluridine, a uridine phoshorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2′-deoxyuridine. Biochem. Pharmacol. 39, 1247-1253.
8. Iltzsch M., H. and Klenk E., E. (1993), Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii. Biochem. Pharmacol. 46, 1849-1858.
9. Kono A., Hara Y., Sugata S., Karube Y., Matsushima Y. and Ishitsuka H. (1983), Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem. Pharm. Bull. 31, 175-178.
10. Krenitsky T. A., Barclay M. and Jacquez J. A. (1964), Specificity of mouse uridine phosphorylase. Chromatography, purification and properties. J. Biol. Chem. 239, 805-812.
11. LaCreta F. P., Warren B. S. and Williams W. M. (1989), Effects of pyrimidine nucleoside phosphorylase inhibitors on hepatic fluoropyrimidine elimination in the rat. Cancer Res. 49, 2567-2573.
12. Langen P., Etzold G. E., Barwolff D. and Prussel B. (1967), Inhibition of thymidine phosphorylase by 6-aminothymine and derivatives of 6-aminouracil. Biochem.Pharmacol. 16, 1833-1837.
13. Lazrek H. B., Redwane N., Rochdi A., Barascut J. L., Imbach J.-L. and De Clercq E. (1995), Synthesis of acycloalkenyl derivatives of pyrimidines and purines. Nucleos. Nucleot. 14, 353-356.
14. Michal G. (1974) Bestimung Von Michaelis-Konstanten und Inhibitor-Konstanten. In: Methoden der enzymatischen Analyse (Bergmayer H. U.), Band I. Verlag Chemie Weinheim/Bergstr., pp. 153-165.
15. Miwa M., Cook A. and Ishitsuka H. (1986), Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells. Chem. Pharm.Bull. 34, 4225-4232.
16. Modrzeiwska H., Greger J., Dramiński M. and Rutkowski M. (1996), The influence of alkoxymethyl purine and pyrimidine acyclonucleosides on growth inhibition of Kirkman-Robbins hepatoma and possible mechanism of their cytostatic activity. Z. Naturforsch. 51c, 75-80.
17. Moghaddam A. and Bicknell R. (1992), Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31, 12142-12146.
18. Moghaddam A., Zhang H.-T., Fan T.-P. D., Hu D.-E., Lees V. C., Turley H., Fox S. B., Gatter K. C. Harris A. L. and Bicknell R. (1995), Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA, 92, 998-1002.
19. 14C in cancer patients. Cancer Res. 23, 49-66.
20. Naguib F. N. M., Levesque D. L., Wang E.-C., Panzica R. P. and El Kouni M. H. (1993), 5-Benzylbarbituric acid derivatives,potent and specific inhibitors of uridine phosphorylase. Biochem.Pharmacol. 46, 1273-1283.
21. Niedzwicki J. G., El Kouni M. H., Chu S. H. and Cha S. (1981), Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase Biochem. Pharmacol. 30, 2097-2101.
22. Niedzwicki J. G., El Kouni M. H., Chu S. H. and Cha S. (1983) Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases. Biochem. Pharmacol. 32, 399-415.
23. Ozierov A.A, Novkov M. C., Brel A.K, Andrejeva O. T., Vladvko G. V., Boreko E. I., Korbachenko L. V., and Vervetchenko C. G., (1991), The synthesis and antiviral activity of newly synthesized unsaturated pyrimidine acyclonucleosides. Chim. Pharm. 25, 44-47.
24. Razzel W. E. (1967), Pyrimidine nucleoside and deoxynucleoside phosphorylases. Methods Enzymol. 12A, 118-125.
25. Rutkowski M., Dramiński M. (1991), Phosphorylation of acyclonucleosides by nucleoside phosphotransferase from higher plants and bacteria. Acta Biochim Polon. 38, 449-457.
26. Sommadossi J.-P., Cretton E. M., Kidd L. B., McClure H. M., Anderson D. C. and El Kouni M. H. (1995), Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in Rhesus monkeys: implications for chemotherapy. Cancer Chem. Pharmacol. 37, 14-22.
27. Sumizawa T., Yoshimura A., Furukawa T., Haraguchi M., Fukui K., Ishizawa M., Yamada Y. and Akiyama S. (1993), Cloning and characterization of thymidine phosphorylase, an activating enzyme for pyrimidine antimetabolites. In: The Mechanism and New Approach on Drug Resistance of Cancer Cells (Miyazaki T., Takaku F., Sakurad K. ed.). Elsevier Sience Publishers B. V. pp. 133-139.
28. Takahaski Y., Bucana C. D., Liu W., Yoneda J., Kitadai Y., Cleary K. R. and Ellis L. M. (1996), Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Nat.-Cancer Inst. 88, 1146-1151.
29. Toi M., Hoshina S., Taniguchi T., Yamamoto Y., Ishitsuka H. and Tominaga T. (1995), Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer. 64, 79-82.
30. Usuki K., Saras J., Waltenberger J., Miyazono K., Pierce G., Thomason A. and Heldin C.-H. (1992), Platelet-derived endothelial cell growth factor has thymidine phosphorvlase activity. Biochem. Biophys. Res. Commun. 184, 1311-1316.
31. Usuki K., Gonez L. J., Wernstedt Ch., Morén A., Miyazono K., Claesson-Welsh L. and Heldin C.-H (1994), Structural properties of 3.0 kb and 3.2 kb transcripts encoding platelet-derived endothelial cell growth factor /thymidine phosphorylase in A4312 cells. Biochim. Biophys. Acta 1222, 411-414.
32. Veres Z., Szabolcs A., Szinai I., Denes G., Kajtar-Peredy M. and Ötvös L. (1985), 5-substituted -2,2′-anhydrouridines, potent inhibitors of uridine phosphorylase. Biochem.Pharmacol. 34, 1737-1740.
33. Veres Z., Schinai I., Szabolcs A., Ujszászy K. and Dénes G. (1987), Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2-2′-anhydrouridine. Drugs Exptl. Clin. Res. 13, 615-621.
34. Woodman P., Sarrif A. M., and Heidelberger Ch. (1980), Inhibition of nucleoside phosphorylase cleavage of 5-fluoro-2′-deoxyuridine by 2,4-pyrimidinedione derivatives. Biochem. Pharmacol. 29, 1059-1063.
35. Woodman P., Sarrif A. M., and Heidelberger Ch. (1980), Specifici of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2′-cleoxyuridine. Cancer. Res. 40, 507-511.
36. Yoshimura A., Kuwazuru Y., Furukawa T., Yoshida H., Yamada K. and Akiyama S. (1990), Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta 1034, 107-113.